Best Industrial Research Award
Thomas Birngruber — JOANNEUM RESEARCH HEALTH, Austria.
Thomas Birngruber is a researcher, whose research publication record includes studies addressing dermal, cerebral, and interstitial pharmacokinetic measurements and pharmaceutical delivery systems. His ORCID record identifies and documented a research portfolio containing pharmaceutical and biomedical studies. [1]
Abstract
Thomas Birngruber’s documented research profile is centered on pharmacokinetics, drug delivery, open flow microperfusion and related biomedical applications. Research profile focused on pharmacokinetics and associated pharmaceutical research methodologies. His ORCID record lists publications addressing dermal, cerebral and interstitial pharmacokinetic measurements, topical formulations and therapeutic agents. [2]
Keywords
Pharmacokinetics; open flow microperfusion; dermal drug delivery; topical pharmaceuticals; bioequivalence; cerebral microperfusion; drug transport; interstitial fluid; pharmaceutical research.
Introduction
The publication record associated with Birngruber includes studies spanning pharmaceutical sciences and biomedical research, with recurring attention to methods for measuring drug concentrations in biological tissues. Birngruber’s documented works apply experimental microperfusion approaches to investigate drug concentrations in skin, brain, and other interstitial compartments.[3]
Research Profile
The Research subject area is pharmacokinetics, while the documented works show particular activity in dermal pharmacokinetics, open flow microperfusion and topical drug research. Recent records include investigations of systemic redistribution, cutaneous bioequivalence and local drug concentrations.The profile also includes collaborative publications in pharmaceutical sciences, biomedical research, and drug-development applications.[4]
Research Contributions
Representative contributions include research using open flow microperfusion to investigate topical drug delivery, dermal pharmacokinetics, cerebral drug transport and interstitial-fluid measurements. The research record also includes collaborative studies involving advanced pharmaceutical formulations and therapeutic antibodies. [5]
Publications
The Research record reports the works displayed in its publication interface and includes recent articles such as a 2026 European Journal of Pharmaceutical Sciences study on cutaneous pharmacokinetic-based bioequivalence and a 2025 Journal of Controlled Release study concerning subcutaneous bioavailability of monoclonal antibodies. [2]
Research Impact
The researcher profile reports 57 documents, 1,209 citations and an h-index of 18. These quantitative indicators are presented as profile for the recognition article. These bibliometric figures provide quantitative indicators of publication and citation activity associated with the researcher profile. His documented research portfolio containing pharmaceutical and biomedical studies.[1]
Award Suitability
For the Scientific World Research Awards, the nomination information identifies the recognition category as Best Industrial Research Award and the subject area as Pharmacokinetics. The documented publication portfolio provides a research basis for describing work in pharmaceutical and biomedical research without assigning claims beyond the record
Conclusion
Thomas Birngruber’s documented profile combines pharmacokinetic research with methodological work involving open flow microperfusion, drug delivery and tissue-level measurement. The ORCID record provides identifiable employment and publication information, while the supplied bibliometric data summarize the research profile presented for this award article.[1]
External Links
References
- ORCID. (2026). Thomas Birngruber, ORCID iD 0000-0001-8827-4660. ORCID.
https://orcid.org/0000-0001-8827-4660
- Crossref. (2026). The Impact of Systemic Redistribution on Cutaneous Pharmacokinetic-Based Bioequivalence. European Journal of Pharmaceutical Sciences.
https://doi.org/10.1016/j.ejps.2026.107673
- Elsevier. (2025). Predicting human subcutaneous bioavailability of monoclonal antibodies using an open flow microperfusion porcine model. Journal of Controlled Release.
https://doi.org/10.1016/j.jconrel.2025.114401
- Elsevier. (2024). Cutaneous pharmacokinetics-based bioequivalence: A clinical dermal open flow microperfusion verification study. European Journal of Pharmaceutical Sciences.
https://doi.org/10.1016/j.ejps.2024.106827
- Elsevier. (2023). Detailed pharmacokinetic characterization of advanced topical acyclovir formulations with IVPT and in vivo Open Flow Microperfusion. International Journal of Pharmaceutics.
https://doi.org/10.1016/j.ijpharm.2023.123269